"We are working on tackling the most prevalent disease in the world today, and are working methodically under the stringent guidelines of the FDA. Our approach is to find synergy in the best treatments available to us and design trials to find effective solutions and satisfy FDA's and ASX's requirements. The nature of the diseases and our weapons against them necessarily mean that a definite and fixed timeline cannot be set. However, our methodical approach has meant that we are on track according to our quarterly schedule as outlined in our AGM's presentation, we will notify the shareholders and the market as soon as therr are verified and meaningful findings. We have had early signs of good results and we remain supremely confident in reaching our goals of introducing effective cancer treatments from our 5 programs. There, i hope this helps.
IMU Price at posting:
8.3¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)